2019 International Congress

Monday, September 23, 2019

1:45pm-3:15pm

Impact of cathine and carthinone use among Parkinson’s disease Patients

S. Zewde (Addis Ababa, Ethiopia)

Quality of Life  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Impact of cathine and cathinone use among Parkinson’s disease Patients

S. Zewde (Addis Ababa, Ethiopia)

Quality of Life  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Impact of ND0612 on patient reported outcomes: A blinded rater study of 2 dosing regimens

F. Stocchi, W. Poewe, S. Oren, R. Case, K. Kieburtz, C. Olanow (Rome, Italy)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Impact of Offering Genetic Testing and Counseling to People with Parkinson’s Disease in a Clinical Setting

A. Naito, J. Beck, C. Casaceli, A. Hall, K. Marder, M. Nance, M. Schwarzschild, T. Simuni, R. Alcalay (Miami, FL, USA)

Genetics  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Impact of oral COMT-inhibitors on gut microbiota and biologically active microbial metabolites in patients with Parkinson’s Disease

D. Grün, V. Zimmer, J. Kauffmann, M. Unger, J. Spiegel, KU. Dillmann, A. Schwiertz, K. Faßbender, M. Fousse (Homburg, Germany)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Impact of repeated oral administration of Opicapone on the plasma pharmacokinetics of levodopa

M. Nomoto, A. Takeda, K. Iwai, A. Nishimura, N. Hattori (Ehime, Japan)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Impact of subthalamic deep brain stimulation on sensorimotor and motor cortical oscillatory activity in free-moving hemiparkinsonian rats

A. Abdulbaki, T. Doll, J. Krauss, M. Alam, K. Schwabe (Hannover, Germany)

Other  ·  Agora 2 West, Level 2

1:45pm-3:15pm

Improvements in gait deficits with peripheral nerve grafts implanted into the substantia nigra in patients with Parkinson’s disease during deep brain stimulation surgery: 2-year follow-up study

G. Gera, K. Rickard, C. Crumpton, A. Borgsmiller, Z. Guduru, C. Horne, G. Qunitero (Lexington, KY, USA)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Impulse Control Disorder (ICD) in the Patient with Parkinson’s Disease (PD)

M. Kulsum, S. Choudhury, A. Ghosh, P. Ghosh (Kolkata, India)

Psychiatric Manifestations  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

In the shadow of Parkinson disease: what to tell patients with REM sleep behavior disorder?

D. Barone, A. Lee, N. Hellmers, S. Lakhani, H. Sarva, C. Henchcliffe (New York, NY, USA)

Restless Leg Syndrome, RBD and Other Sleep Disorders  ·  Les Muses Terrace, Level 3